Cardiomyocyte Sirt (Sirtuin) 7 Ameliorates Stress-Induced Cardiac Hypertrophy by Interacting With and Deacetylating GATA4.


Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
01 2020
Historique:
pubmed: 19 11 2019
medline: 25 7 2020
entrez: 19 11 2019
Statut: ppublish

Résumé

Sirt (Sirtuin) 7, the most recently identified mammalian sirtuin, has been shown to contribute to appropriate wound healing processes after acute cardiovascular insult. However, its role in the development of cardiac remodeling after pressure overload is unclear. Cardiomyocyte-specific Sirt7-knockout and control mice were subjected to pressure overload induced by transverse aortic constriction. Cardiac hypertrophy and functions were then examined in these mice. Sirt7 protein expression was increased in myocardial tissue after pressure overload. Transverse aortic constriction-induced increases in heart weight/tibial length were significantly augmented in cardiomyocyte-specific Sirt7-knockout mice compared with those of control mice. Histological analysis showed that the cardiomyocyte cross-sectional area and fibrosis area were significantly larger in cardiomyocyte-specific Sirt7-deficient mice. Cardiac contractile functions were markedly decreased in cardiomyocyte-specific Sirt7-deficient mice. Mechanistically, we found that Sirt7 interacted directly with GATA4 and that the exacerbation of phenylephrine-induced cardiac hypertrophy by Sirt7 knockdown was decreased by GATA4 knockdown. Sirt7 deacetylated GATA4 in cardiomyocytes and regulated its transcriptional activity. Interestingly, we demonstrated that treatment with nicotinamide mononucleotide, a known key NAD

Identifiants

pubmed: 31735083
doi: 10.1161/HYPERTENSIONAHA.119.13357
doi:

Substances chimiques

GATA4 Transcription Factor 0
Gata4 protein, mouse 0
Sirt7 protein, mouse 0
Sirtuins EC 3.5.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

98-108

Auteurs

Satoru Yamamura (S)

From the Departments of Cardiovascular Medicine (S.Y., S.A., T.N., Y.K., S.H., T. Yamada, T.I., M.Y., Y.O., Y.A., E.Y., K.S., K.K., K.T.), Faculty of Life Sciences, Kumamoto University, Japan.

Yasuhiro Izumiya (Y)

Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, Japan (Y.I.).

Satoshi Araki (S)

From the Departments of Cardiovascular Medicine (S.Y., S.A., T.N., Y.K., S.H., T. Yamada, T.I., M.Y., Y.O., Y.A., E.Y., K.S., K.K., K.T.), Faculty of Life Sciences, Kumamoto University, Japan.
Medical Biochemistry (S.A., T. Yoshizawa, K.Y.), Faculty of Life Sciences, Kumamoto University, Japan.

Taishi Nakamura (T)

From the Departments of Cardiovascular Medicine (S.Y., S.A., T.N., Y.K., S.H., T. Yamada, T.I., M.Y., Y.O., Y.A., E.Y., K.S., K.K., K.T.), Faculty of Life Sciences, Kumamoto University, Japan.

Yuichi Kimura (Y)

From the Departments of Cardiovascular Medicine (S.Y., S.A., T.N., Y.K., S.H., T. Yamada, T.I., M.Y., Y.O., Y.A., E.Y., K.S., K.K., K.T.), Faculty of Life Sciences, Kumamoto University, Japan.

Shinsuke Hanatani (S)

From the Departments of Cardiovascular Medicine (S.Y., S.A., T.N., Y.K., S.H., T. Yamada, T.I., M.Y., Y.O., Y.A., E.Y., K.S., K.K., K.T.), Faculty of Life Sciences, Kumamoto University, Japan.

Toshihiro Yamada (T)

From the Departments of Cardiovascular Medicine (S.Y., S.A., T.N., Y.K., S.H., T. Yamada, T.I., M.Y., Y.O., Y.A., E.Y., K.S., K.K., K.T.), Faculty of Life Sciences, Kumamoto University, Japan.

Toshifumi Ishida (T)

From the Departments of Cardiovascular Medicine (S.Y., S.A., T.N., Y.K., S.H., T. Yamada, T.I., M.Y., Y.O., Y.A., E.Y., K.S., K.K., K.T.), Faculty of Life Sciences, Kumamoto University, Japan.

Masahiro Yamamoto (M)

From the Departments of Cardiovascular Medicine (S.Y., S.A., T.N., Y.K., S.H., T. Yamada, T.I., M.Y., Y.O., Y.A., E.Y., K.S., K.K., K.T.), Faculty of Life Sciences, Kumamoto University, Japan.

Yoshiro Onoue (Y)

From the Departments of Cardiovascular Medicine (S.Y., S.A., T.N., Y.K., S.H., T. Yamada, T.I., M.Y., Y.O., Y.A., E.Y., K.S., K.K., K.T.), Faculty of Life Sciences, Kumamoto University, Japan.

Yuichiro Arima (Y)

From the Departments of Cardiovascular Medicine (S.Y., S.A., T.N., Y.K., S.H., T. Yamada, T.I., M.Y., Y.O., Y.A., E.Y., K.S., K.K., K.T.), Faculty of Life Sciences, Kumamoto University, Japan.

Eiichiro Yamamoto (E)

From the Departments of Cardiovascular Medicine (S.Y., S.A., T.N., Y.K., S.H., T. Yamada, T.I., M.Y., Y.O., Y.A., E.Y., K.S., K.K., K.T.), Faculty of Life Sciences, Kumamoto University, Japan.

Yoichi Sunagawa (Y)

Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Japan (Y.S., T.M.).

Tatsuya Yoshizawa (T)

Medical Biochemistry (S.A., T. Yoshizawa, K.Y.), Faculty of Life Sciences, Kumamoto University, Japan.

Naomi Nakagata (N)

Division of Reproductive Engineering, Center for Animal Resources and Development (N.N.), Kumamoto University, Japan.

Eva Bober (E)

Department of Cardiac Development and Remodeling, Max-Planck-Institute for Heart and Lung Research, Bad Nauheim, Germany (E.B., T.B.).

Thomas Braun (T)

Department of Cardiac Development and Remodeling, Max-Planck-Institute for Heart and Lung Research, Bad Nauheim, Germany (E.B., T.B.).

Kenji Sakamoto (K)

From the Departments of Cardiovascular Medicine (S.Y., S.A., T.N., Y.K., S.H., T. Yamada, T.I., M.Y., Y.O., Y.A., E.Y., K.S., K.K., K.T.), Faculty of Life Sciences, Kumamoto University, Japan.

Koichi Kaikita (K)

From the Departments of Cardiovascular Medicine (S.Y., S.A., T.N., Y.K., S.H., T. Yamada, T.I., M.Y., Y.O., Y.A., E.Y., K.S., K.K., K.T.), Faculty of Life Sciences, Kumamoto University, Japan.

Tatsuya Morimoto (T)

Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Japan (Y.S., T.M.).

Kazuya Yamagata (K)

Medical Biochemistry (S.A., T. Yoshizawa, K.Y.), Faculty of Life Sciences, Kumamoto University, Japan.
Center for Metabolic Regulation of Healthy Aging, Faculty of Life Sciences (K.Y., K.T.), Kumamoto University, Japan.

Kenichi Tsujita (K)

From the Departments of Cardiovascular Medicine (S.Y., S.A., T.N., Y.K., S.H., T. Yamada, T.I., M.Y., Y.O., Y.A., E.Y., K.S., K.K., K.T.), Faculty of Life Sciences, Kumamoto University, Japan.
Center for Metabolic Regulation of Healthy Aging, Faculty of Life Sciences (K.Y., K.T.), Kumamoto University, Japan.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH